Clinical trials
Observational Lymphoma, B-Cell, Marginal Zone trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
66 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 9 |
| 2009 | 6 |
| 2010 | 3 |
| 2013 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Recruiting | 16 |
| Terminated | 9 |
| Unknown status | 7 |
| Not yet recruiting | 5 |
| Active, not recruiting | 4 |
| Withdrawn | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vanderbilt-Ingram Cancer Center | 5 |
| City of Hope Medical Center | 3 |
| Hospices Civils de Lyon | 3 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 3 |
| International Extranodal Lymphoma Study Group (IELSG) | 3 |
| Mayo Clinic | 3 |
| Ruijin Hospital | 3 |
| iOMEDICO AG | 3 |
| Case Comprehensive Cancer Center | 2 |
| SWOG Cancer Research Network | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell, Marginal Zone | 66 |
| Lymphoma, Follicular | 47 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 44 |
| Lymphoma, Large B-Cell, Diffuse | 42 |
| Lymphoma, Mantle-Cell | 42 |
| Lymphoma, Non-Hodgkin | 39 |
| Burkitt Lymphoma | 32 |
| Lymphoma | 30 |
| Lymphoma, Large-Cell, Immunoblastic | 30 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 29 |
Trials
Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.